» Articles » PMID: 36335129

LINC00839 Promotes Malignancy of Liver Cancer Via Binding FMNL2 Under Hypoxia

Overview
Journal Sci Rep
Specialty Science
Date 2022 Nov 6
PMID 36335129
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cancer is one of the most common malignant tumors in the world and metastasis is the leading cause of death associated with liver cancer. Hypoxia is a common feature of solid tumors and enhances malignant character of cancer cells. However, the exact mechanisms involved in hypoxia-driven liver cancer progression and metastasis have not been well clarified so far. The aim of this study was to investigate the contribution of long non-coding RNA (lncRNA) in hypoxia promoting liver cancer progression. We screened and revealed LINC00839 as a novel hypoxia-responsive lncRNA in liver cancer. LINC00839 expression was up-regulated in liver cancer tissues and cell lines, and the patients with high LINC00839 expression had shortened overall survival. LINC00839 further overexpressed under hypoxia and promoted liver cancer cell proliferation, migration, and invasion. Mechanistically, LINC00839 bound multiple proteins that were primarily associated with the metabolism and RNA transport, and positively regulated the expression of Formin-like protein 2 (FMNL2). LINC00839 could promote hypoxia-mediated liver cancer progression, suggesting it may be a clinically valuable biomarker and serve as a molecular target for the diagnosis, prognosis, and therapy of liver cancer.

Citing Articles

Exosomal long non-coding RNA-LINC00839 promotes lung adenocarcinoma progression by activating NF-κB signaling pathway.

Sun Y, Zhen F, Wang H, Liang X, Wang Y, Wang F Ann Med. 2024; 56(1):2430029.

PMID: 39582330 PMC: 11590188. DOI: 10.1080/07853890.2024.2430029.


LINC00839 in Human Disorders: Insights into its Regulatory Roles and Clinical Impact, with a Special Focus on Cancer.

Hu Y, Hu Y, Lu X, Luo H, Chen Z J Cancer. 2024; 15(8):2179-2192.

PMID: 38495499 PMC: 10937278. DOI: 10.7150/jca.93820.


Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma.

Tang J, Yao F, Yao Z, Xing X Aging (Albany NY). 2023; 15(18):9695-9717.

PMID: 37728407 PMC: 10564438. DOI: 10.18632/aging.205043.


Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1.

Liu Y, Zhang H, Liu Y, Zhang S, Su P, Wang L Autophagy. 2023; 19(9):2443-2463.

PMID: 36803235 PMC: 10392732. DOI: 10.1080/15548627.2023.2182482.

References
1.
Eales K, Hollinshead K, Tennant D . Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016; 5:e190. PMC: 4728679. DOI: 10.1038/oncsis.2015.50. View

2.
Carnero A, Lleonart M . The hypoxic microenvironment: A determinant of cancer stem cell evolution. Bioessays. 2016; 38 Suppl 1:S65-74. DOI: 10.1002/bies.201670911. View

3.
Packer L, Fuehr K . Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature. 1977; 267(5610):423-5. DOI: 10.1038/267423a0. View

4.
Mierke C . The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells. Rep Prog Phys. 2019; 82(6):064602. DOI: 10.1088/1361-6633/ab1628. View

5.
Jiao X, Wang B, Feng C, Song S, Tian B, Zhou C . Formin-like protein 2 promotes cell proliferation by a p27-related mechanism in human breast cancer cells. BMC Cancer. 2021; 21(1):760. PMC: 8247103. DOI: 10.1186/s12885-021-08533-w. View